Vertex Pharmaceuticals financial statements

버텍스 파머슈티컬NASDAQ:VRTX · Nasdaq · Healthcare · sector #16
$502.31-0.24%
2026-10-06 close · prelim

Vertex Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $11.02B. 2024 operating profit was −$233M.

Reported results

Vertex Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q